| abstract |
[Problem] The present invention addresses the problem of providing a novel hENaC αβγ activating agent. [Solution] Provided is a hENaC αβγ activating agent including, as an effective component, a compound or a salt thereof having a structure identical to or similar to 3-chloro-N-(2-((1,1-dioxidetetrahydrothiophene-3-yl)amino)-2-oxoethyl)-N-ethylbenzo[β]thiophene-2-carboxyamide, which is represented by formula (1). Utilization of this hENaC αβγ activating agent contributes to further development of drugs, the food industry, and the health sciences. |